Elizabeth Arden Inc.’s (RDEN) share price has entered into oversold territory with a stochastic value of 13.81. The Zacks Consensus Estimate on the company’s earnings for the year ending June 2010 has increased by 7 cents over the past 2 months to 70 cents per share. Elizabeth Arden is a Zacks #2 Rank (“Buy") company."RDEN" Free Stock Analysis: Buy? Sell? Hold?Zacks Investment Research

As of this writing, the Dow and NASDAQ are each down by more than 1%, but Elizabeth Arden, Inc. (RDEN) finds itself up by more than 3%.

< ?DART(15);?> On such a difficult day, that advance is more than enough to make the Zacks #1 Rank Top Performers List for Friday. Volume is about 300,000 shares, which is well above the daily average of 134,000.

RDEN has strung together a number of quarters with better-than-expected earnings, and earnings estimates remain above levels from 2 months ago due to a solid fiscal first quarter performance.

Elizabeth Arden is a global prestige beauty products company with an extensive portfolio of prestige beauty brands sold in more than 100 countries. It is the only company from the cosmetics & toiletries industry on today's Zacks #1 Rank List.

6 Straight Beats

...

Elizabeth Arden Inc.’s (RDEN) share price has entered into oversold territory with a stochastic value of 14.61. Analysts have been increasing their estimates on the company’s full-year earnings, sending the Zacks Consensus Estimate up by 2 cents over the past 2 months to 63 cents per share. Elizabeth Arden is a Zacks #1 Rank (“Strong Buy") company."RDEN" Free Stock Analysis: Buy? Sell? Hold?Zacks Investment Research

Here are the stocks added to the Zacks #1 Rank ("strong buy") List today:

3D Systems Corp (TDSC) 8x8 Inc (EGHT) Acuity Brands Inc (AYI) Amerco Inc (UHAL) AMICAS Inc (AMCS) Beneficial Mutual Bancorp Inc (BNCL) BP Prudhoe Bay Royalty Trust (BPT) BASF SE (BF.B) Del Monte Foods Co (DLM) DeVry Inc (DV) Domtar Corp (UFS) Drew Industries Inc (DW) DryShips Inc (DRYS) Eastman Chemical Co (EMN) Elizabeth Arden Inc (RDEN) Enbridge Energy Management LLC (EEQ) Encore Capital Group Inc (ECPG) ...

Elizabeth Arden Inc.’s (RDEN) share price has entered into oversold territory with a stochastic value of 15.85. Analysts have been increasing their estimates on the company’s earnings for the year ending June 2010, sending the Zacks Consensus Estimate up by 2 cents over the past month to 63 cents per share. Elizabeth Arden is a Zacks #1 Rank (“Strong Buy") company."RDEN" Free Stock Analysis: Buy? Sell? Hold?Zacks Investment Research

Here are the stocks added to the Zacks #1 Rank ("strong buy") List today:

AMICAS Inc (AMCS) Avago Technologies Ltd (AVGO) RG Barry Corp (DFZ) Bio-Rad Laboratories Inc (BIO) Bway Holding Co (BWY) Cabela's Inc (CAB) Carrols Restaurant Group Inc (TAST) China Green Agriculture Inc (CGA) Clearwater Paper Corp (CLW) Collective Brands Inc (PSS) Commerce Bancshares Inc (CBSH) Cytec Industries Inc (CYT) Deckers Outdoor Corp (DECK) Del Monte Foods Co (DLM) DryShips Inc (DRYS) Elizabeth Arden Inc (RDEN) EnerNOC Inc (ENOC) ...

Here are the stocks added to the Zacks #1 Rank ("strong buy") List today:

3M Co (MMM) Cia de Bebidas das Americas (ABV) AMICAS Inc (AMCS) AudioCodes Ltd (AUDC) Banco de Chile (BCH) Banco Santander Chile (SAN) Big 5 Sporting Goods Corp (BGFV) Briggs & Stratton Corp (BGG) Cabela's Inc (CAB) Cabot Corp (CBT) Conceptus Inc (CPTS) Conexant Systems Inc (CNXT) Corinthian Colleges Inc (COCO) Drew Industries Inc (DW) Elbit Systems Ltd (ESLT) Elizabeth Arden Inc (RDEN) Enbridge Energy Management LLC (...

Elizabeth Arden Inc.’s (RDEN) share price has entered into oversold territory with a stochastic value of 12.03. The Zacks Consensus Estimate on the company’s earnings for the year ending June 2010 has moved up 2 cents over the past week to 61 cents per share. Elizabeth Arden is a Zacks #1 Rank (“Strong Buy”) company."RDEN" Free Stock Analysis: Buy? Sell? Hold?Zacks Investment Research

Beauty products maker Elizabeth Arden Inc. (RDEN) reported fiscal fourth-quarter results yesterday after the closing bell. The company recorded a narrower GAAP net loss of $3.6 million, compared to a loss of $10.4 million in year-ago period. Excluding restructuring and certain other expenses, loss per share came in at 7 cents per share, which squeezed past the Zacks Consensus Estimate by a penny. Elizabeth Arden is a global prestige beauty products company with a portfolio of brands sold in over 100 countries. The company's portfolio comprise of Elizabeth Arden skincare, color, and fragrance products, Prevage anti-aging treatments, celebrity and designer fragrance brands. In May last year, the company signed a deal with Liz Claiborne (LIZ) to make, distribute and market the latter’s fragrance brands. The Miramar, FL-based company recorded a 10% year-over-year decline in sales to $212.6 million as performance was adversely affected by ...

DrStockPick.com Stock Report!

Friday August 14, 2009

**************************************************************

King Pharmaceuticals Inc. (NYSE: KG) said Thursday the Food and Drug Administration approved its drug Embeda, a painkiller that is designed to be abuse-resistant. The FDA approval covers the use of Embeda for moderate to severe chronic pain. Embeda’s primary ingredient is morphine, but the pills contain a core of a second drug called naltrexone. If the pill is taken normally, it will release the morphine. However if it is crushed or chewed, the naltrexone is released, canceling out the high from the morphine.

Blockbuster Inc. (NYSE: BBI)’s second-quarter loss narrowed as the struggling video rental chain cut costs amid declines

...